NO20063603L - Fremgangsmate for vaksinering mot BVDV-infeksjon i testikkel - Google Patents

Fremgangsmate for vaksinering mot BVDV-infeksjon i testikkel

Info

Publication number
NO20063603L
NO20063603L NO20063603A NO20063603A NO20063603L NO 20063603 L NO20063603 L NO 20063603L NO 20063603 A NO20063603 A NO 20063603A NO 20063603 A NO20063603 A NO 20063603A NO 20063603 L NO20063603 L NO 20063603L
Authority
NO
Norway
Prior art keywords
testicle
procedure
vaccination against
bvdv infection
against bvdv
Prior art date
Application number
NO20063603A
Other languages
English (en)
Norwegian (no)
Inventor
Michael Aaron Ellsworth
Cassius Mcallister Tucker
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of NO20063603L publication Critical patent/NO20063603L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24311Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20063603A 2004-03-17 2006-08-09 Fremgangsmate for vaksinering mot BVDV-infeksjon i testikkel NO20063603L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55386704P 2004-03-17 2004-03-17
PCT/IB2005/000610 WO2005089793A1 (en) 2004-03-17 2005-03-04 Method of vaccination against testicular bvdv infection

Publications (1)

Publication Number Publication Date
NO20063603L true NO20063603L (no) 2006-09-08

Family

ID=34961163

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063603A NO20063603L (no) 2004-03-17 2006-08-09 Fremgangsmate for vaksinering mot BVDV-infeksjon i testikkel

Country Status (23)

Country Link
US (1) US20080260778A1 (pl)
EP (1) EP1727562B1 (pl)
JP (1) JP4105220B2 (pl)
KR (2) KR20080036160A (pl)
CN (1) CN1929859A (pl)
AR (1) AR048671A1 (pl)
AT (1) ATE398462T1 (pl)
AU (1) AU2005224179B2 (pl)
BR (1) BRPI0508941A (pl)
CA (1) CA2560532A1 (pl)
DE (1) DE602005007584D1 (pl)
DK (1) DK1727562T3 (pl)
ES (1) ES2306101T3 (pl)
NO (1) NO20063603L (pl)
NZ (1) NZ549592A (pl)
PL (1) PL1727562T3 (pl)
PT (1) PT1727562E (pl)
RU (1) RU2335298C2 (pl)
SI (1) SI1727562T1 (pl)
TW (1) TWI306404B (pl)
UA (1) UA86405C2 (pl)
WO (1) WO2005089793A1 (pl)
ZA (1) ZA200607132B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
MX347911B (es) * 2010-09-21 2017-05-17 Intervet Int Bv Vacuna contra virus de diarrea viral de bovinos.
AR084358A1 (es) 2010-12-27 2013-05-08 Lilly Co Eli Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
WO2012092053A1 (en) * 2010-12-27 2012-07-05 Eli Lilly And Company Bovine viral diarrhea virus type 1b vaccine compositions and methods
US9480739B2 (en) * 2013-03-15 2016-11-01 Intervet Inc. Bovine virus vaccines that are liquid stable
CN107823639B (zh) * 2017-11-10 2020-10-02 齐鲁动物保健品有限公司 牛病毒性腹泻病毒灭活疫苗及其制备方法
WO2025172363A1 (en) * 2024-02-12 2025-08-21 Hipra Scientific, S.L.U. Vaccine against bovine viral diarrohea virus and bovine respiratory disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593873A (en) * 1986-01-27 1997-01-14 Syntro Corporation Recombinant infectious bovine rhinotracheitis virus
US5709865A (en) * 1994-11-10 1998-01-20 Biostar Inc. Immunogenic composition against Bovine Viral Diarrhea Virus II glycoprotein 53 (BVDV-II gp53)
US6001613A (en) * 1996-05-24 1999-12-14 Board Of Regents Of University Of Nebraska Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
US6174667B1 (en) * 1997-09-23 2001-01-16 Cornell Research Foundation, Inc. Bovine viral diarrhea virus serum antigen capture
US6606457B2 (en) * 2001-06-19 2003-08-12 Pentax Corporation Focused image tremble correcting device
ATE354681T1 (de) * 2001-08-09 2007-03-15 Idexx Lab Inc Nachweis des virus der viralen rinderdiarrhoe in gewebsproben

Also Published As

Publication number Publication date
RU2335298C2 (ru) 2008-10-10
UA86405C2 (ru) 2009-04-27
ATE398462T1 (de) 2008-07-15
DK1727562T3 (da) 2008-09-15
TWI306404B (en) 2009-02-21
ZA200607132B (en) 2008-08-27
ES2306101T3 (es) 2008-11-01
KR20080036160A (ko) 2008-04-24
CN1929859A (zh) 2007-03-14
US20080260778A1 (en) 2008-10-23
AU2005224179A1 (en) 2005-09-29
BRPI0508941A (pt) 2007-08-14
SI1727562T1 (sl) 2008-10-31
EP1727562A1 (en) 2006-12-06
EP1727562B1 (en) 2008-06-18
AR048671A1 (es) 2006-05-17
AU2005224179B2 (en) 2007-08-23
PT1727562E (pt) 2008-09-05
WO2005089793A1 (en) 2005-09-29
KR20060127199A (ko) 2006-12-11
TW200531701A (en) 2005-10-01
DE602005007584D1 (de) 2008-07-31
JP4105220B2 (ja) 2008-06-25
CA2560532A1 (en) 2005-09-29
NZ549592A (en) 2008-12-24
RU2006133328A (ru) 2008-03-27
PL1727562T3 (pl) 2008-10-31
JP2007529498A (ja) 2007-10-25

Similar Documents

Publication Publication Date Title
EA200901241A1 (ru) Соединения для лечения гепатита с
NO20070751L (no) Inhibitorer av HCV-replifikasjon
EA200970805A1 (ru) Ингибиторы серинпротеаз для лечения hcv инфекций
DK2203430T3 (da) N-phenyl-dioxo-hydropyrimidiner anvendelige som inhibitorer for hepatitis C virus (HCV)
EA200900676A1 (ru) Ингибиторы вируса гепатита с
EA200702493A1 (ru) Соединения и способы лечения или предотвращения флавивирусных инфекций
EA200900156A1 (ru) Пиридазиновое соединение (варианты), способ его получения (варианты), способ лечения или профилактики инфекционного вирусного гепатита с с его помощью, композиция и лекарственное средство на его основе
NO20090453L (no) Hepatitt C Virusinhibitorer
EA201270275A1 (ru) Кристаллическое соединение пиридазина
EA201000201A1 (ru) Азотсодержащие бициклические химические вещества для лечения вирусных инфекций
EA201200890A1 (ru) Комбинированная терапия hcv
TNSN07252A1 (en) Indole derivatives for treating viral infections
NO20072235L (no) HCV-hemmende bicykliske pyrimidiner
NO20091704L (no) Inhibitorer av hepatitt C virus
NO20091707L (no) Inhibitorer av hepatitt C virus
EA201200669A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
NO20075616L (no) Tripeptider som hepatitt C virus inhibitorer
DK1951296T4 (da) Celleafledte viral vacciner med lave niveauer af restcelle-DNA
WO2008021936A3 (en) Hepatitis c virus inhibitors
EA201001275A1 (ru) Конформационно-ограниченные бифенильные производные для применения в качестве ингибиторов вируса гепатита с
EA200800760A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
EA201390538A1 (ru) Противовирусные соединения
EA201000277A1 (ru) Соединения для лечения гепатита с
EA200701850A1 (ru) Соединения трициклических нуклеозидов (варианты), фармацевтическая композиция на их основе и способ лечения или профилактики вирусных инфекций у млекопитающих
EA200500584A1 (ru) Нуклеозидные производные для лечения инфекционных заболеваний, вызванных вирусом гепатита c

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application